Livzon Pharmaceutical Group repurchases H and A shares

Livzon Pharmaceutical Group Inc (HKEX: 1513) has filed a next-day disclosure return revealing ongoing repurchases of both its H shares and A shares. The filing details a series of H share repurchases throughout July, September, November, and December of 2024, as well as January, February, April 2025 with individual transactions ranging from 7,100 to 548,300 shares at prices between HKD 23.89 and HKD 27.68 per share. Additionally, A shares were actively repurchased from December 2024 through April 2025, with individual transactions ranging from 144,000 to 561,400 shares, and costing between RMB 34.22 and RMB 38.18 each. On April 16, 2025, the company repurchased 145,400 A shares with an aggregate price of RMB 4,996,896. These repurchases are executed on the Shenzhen Stock Exchange.